Press Releases

17 Jul 2024

New research reveals link between spinal muscular atrophy (SMA) and liver damage.

An international study has discovered that people living with the neurodegenerative condition Spinal Muscular Atrophy (SMA) are at higher risk of developing fatty liver disease, suggesting that SMA patients may face additional health problems over time. This finding raises significant concerns about long-term care and health outcomes for individuals with SMA.

01 Jul 2024

NUS Medicine and 22Health Ventures announce joint healthtech accelerator

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and 22Health Ventures, an early-stage healthtech investment firm (22Health), announced their joint accelerator programme, NUS Medicine Digital Advanced Technology Accelerator (DATA), an NUS Medicine – 22Health Ventures partnership (the Accelerator).

19 Jun 2024

Using digital technology and data to sustain intermittent fasting and improve health outcomes: one man’s journey

A researcher from the National University of Singapore was the subject of his own digital health study, in which he embarked on a 7-month journey of 20-hour fasts coupled with a fitness regimen and clean eating.

13 Jun 2024

Neural balance in the brain is associated with brain maturity and better cognitive ability: National University of Singapore study

In a world where external and internal stimuli can throw our entire body system off balance, how does our brain prevent itself from becoming overly stimulated?

06 Jun 2024

NUS Medicine researchers engineer bacteria for targeted chemotherapy delivery

NUS Medicine researchers have identified a new method for delivering chemotherapy drugs directly to tumour sites by utilising the natural interactions between bacteria and cancer cells.

04 Jun 2024

A promising vaccine approach to induce longer-lasting protective immunity against COVID-19: NUS Medicine-Monash University study

A scientific team from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and Monash University, Australia, has engineered a COVID-19 vaccine that induced – in pre-clinical models – very long-lasting, protective immunity against SARS-CoV-2 virus with a single-shot immunisation.

28 May 2024

Insights into functions of micronutrient transporters may pave way for new treatments for neurological diseases

The nutrients in our bodies help to provide daily energy and power the maintenance of cellular structure and function. But how do nutrients get distributed throughout the body in a specific manner?

25 May 2024

Singapore ramps up cancer fight with S$50 million in national grant funding for Precision Oncology

Singapore Ministry of Health through the National Medical Research Council (NMRC), Office, MOH Holdings, Pte Ltd, has awarded S$50 million in national grants to two multi-institution Singapore teams for precision oncology research aimed at improving outcomes for lymphoma and colorectal cancer.

06 May 2024

Little-known protein choline transporter in brain may be key therapeutic target for ageing and Alzheimer’s disease

In a groundbreaking study published in Cell Research, researchers from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) have unveiled unexpected findings that could pave the way for novel therapeutic interventions in Alzheimer’s disease and other neurological disorders.

30 Apr 2024

Singapore study identifies immunity threshold for protection against COVID-19 in children

Immune response from two doses of mRNA vaccines is sufficient to protect against COVID-19 in children. A third dose does not confer additional benefit, research conducted by the NUS Yong Loo Lin School of Medicine (NUS Medicine) and Duke-NUS Medical School has found.